Harvest Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.1M Buy
49,515
+14,580
+42% +$6.51M 1.04% 16
2025
Q1
$15.6M Buy
34,935
+19,710
+129% +$8.82M 0.77% 21
2024
Q4
$6.08M Buy
15,225
+3,307
+28% +$1.32M 0.28% 58
2024
Q3
$5.54M Sell
11,918
-101
-0.8% -$47K 0.33% 56
2024
Q2
$5.63M Buy
12,019
+3,499
+41% +$1.64M 0.41% 45
2024
Q1
$3.56M Buy
8,520
+5,194
+156% +$2.17M 0.32% 60
2023
Q4
$1.33M Sell
3,326
-653
-16% -$262K 0.21% 66
2023
Q3
$1.38M Buy
3,979
+766
+24% +$266K 0.24% 59
2023
Q2
$1.13M Buy
3,213
+1,143
+55% +$402K 0.23% 59
2023
Q1
$651K Sell
2,070
-1,114
-35% -$350K 0.14% 77
2022
Q4
$903K Buy
3,184
+616
+24% +$175K 0.23% 61
2022
Q3
$743K Buy
2,568
+2,118
+471% +$613K 0.22% 61
2022
Q2
$127K Hold
450
0.04% 254
2022
Q1
$117K Buy
+450
New +$117K 0.02% 314
2021
Q3
Sell
-101
Closed -$20K 819
2021
Q2
$20K Sell
101
-151
-60% -$29.9K ﹤0.01% 622
2021
Q1
$54K Sell
252
-635
-72% -$136K 0.01% 390
2020
Q4
$209K Sell
887
-1,121
-56% -$264K 0.02% 150
2020
Q3
$540K Sell
2,008
-50
-2% -$13.4K 0.04% 81
2020
Q2
$589K Buy
2,058
+108
+6% +$30.9K 0.05% 61
2020
Q1
$463K Buy
1,950
+423
+28% +$100K 0.05% 66
2019
Q4
$358K Buy
1,527
+1,067
+232% +$250K 0.04% 77
2019
Q3
$78K Buy
460
+124
+37% +$21K 0.01% 221
2019
Q2
$62K Sell
336
-1,147
-77% -$212K 0.01% 265
2019
Q1
$273K Buy
1,483
+599
+68% +$110K 0.05% 89
2018
Q4
$146K Hold
884
0.03% 144
2018
Q3
$170K Buy
+884
New +$170K 0.03% 194
2018
Q2
Sell
-527
Closed -$85K 337
2018
Q1
$85K Buy
+527
New +$85K 0.01% 131
2017
Q4
Sell
-678
Closed -$103K 252
2017
Q3
$103K Hold
678
0.01% 94
2017
Q2
$87K Buy
+678
New +$87K 0.01% 107